TATess Av Afanasyeva

Tess Av Afanasyeva

*This is an algorithmically generated author record based on publicly available information.

Tess Av Afanasyeva has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Instrument-Software Synergy in Proteomics: Systematic Evaluation Across Mass Spectrometry Platforms, Search Engines, and Rescoring Methods

    by Sander Heyndrickx, Robbin Bouwmeester, Arthur Declercq, Robbe Devreese, Magnus Palmblad, Wout Bittremieux, Tess Av Afanasyeva, Joel Lapin, Arzu Tugce Guler, Pierre-Olivier Schmit, et al.

  • Open Access

    Hardware Software Synergy in Proteomics: Systematic Evaluation Across Mass Spectrometry Platforms, Search Engines, and Rescoring Methods

    by Sander Heyndrickx, Robbin Bouwmeester, Arthur Declercq, Robbe Devreese, Magnus Palmblad, Wout Bittremieux, Tess Av Afanasyeva, Joel Lapin, Arzu Tugce Guler, Pierre-Olivier Schmit, et al.

    Mass spectrometry-based proteomics has advanced through parallel improvements in hardware (instrumentation) and software (data analysis), yet whether these improvements interact synergistically or provide diminishing returns remains unclear. Here, we systematically evaluate hardware-software co-evolution across eight mass spectrometry platforms, three generations of search engines, and multiple rescoring approaches, yielding 72 unique hardware–software combinations spanning from 2004–2024. Our results reveal that hardware and software improvements produce synergistic rather than substitutive benefits. Here, machine learning-based rescoring consistently identifies peptides from low-intensity precursors that produce noisier, more challenging spectra. Crucially, because of increased sensitivity and speed, modern instruments detect more low-intensity precursors, increasing the population of challenging spectra where rescoring provides the greatest benefit. However, this expanded detection depth comes at a cost: recovered low-abundance peptides exhibit inherently higher quantification error, creating a fundamental trade-off between proteome coverage and quantification accuracy. Together, these findings provide a systematic overview of how hardware and software advances have jointly shaped proteomics performance over the past two decades.

  • Open Access

    Hardware Software Synergy in Proteomics: Systematic Evaluation Across Mass Spectrometry Platforms, Search Engines, and Rescoring Methods

    by Sander Heyndrickx, Robbin Bouwmeester, Arthur Declercq, Robbe Devreese, Magnus Palmblad, Wout Bittremieux, Tess Av Afanasyeva, Joel Lapin, Arzu Tugce Guler, Pierre-Olivier Schmit, et al.

    Mass spectrometry-based proteomics has advanced through parallel improvements in hardware (instrumentation) and software (data analysis), yet whether these improvements interact synergistically or provide diminishing returns remains unclear. Here, we systematically evaluate hardware-software co-evolution across eight mass spectrometry platforms, three generations of search engines, and multiple rescoring approaches, yielding 72 unique hardware-software combinations spanning from 2004-2024. Our results reveal that hardware and software improvements produce synergistic rather than substitutive benefits. Here, machine learning-based rescoring consistently identifies peptides from low-intensity precursors that produce noisier, more challenging spectra. Crucially, because of increased sensitivity and speed, modern instruments detect more low-intensity precursors, increasing the population of challenging spectra where rescoring provides the greatest benefit. However, this expanded detection depth comes at a cost: recovered low-abundance peptides exhibit inherently higher quantification error, creating a fundamental trade-off between proteome coverage and quantification accuracy. Together, these findings provide a systematic overview of how hardware and software advances have jointly shaped proteomics performance over the past two decades.

  • Open Access

    Identifying pyrogenic contaminants using transcriptomic profiling of monocyte activation test with machine learning

    by Tess Av Afanasyeva, Bruno Fm de Albuquerque, Paulien Doodeman, Miranda C Dieker-Meijer, Marijke Molenaar-De Backer, Teunis Jp van Dam, Anja Ten Brinke

    The monocyte activation test is an in vitro pyrogenicity assessment method that can utilise human peripheral blood mononuclear cells to detect pyrogens in injectable drugs, providing a binary outcome that indicates the presence or absence of a pyrogen. The added ability to distinguish between different types of pyrogens would greatly expand the applicability of the test, for example, by allowing to pinpoint the source of a contaminating pyrogen in pharmaceutical products. Pyrogens activate a unique set of pattern recognition receptors (PRRs), which contribute to inflammation, yielding distinct transcriptomic activation signatures. In this paper, we capture the unique expression signatures of activated monocytes through bulk RNA sequencing and introduce a data preprocessing pipeline that allows the training of a machine-learning model to classify pyrogenic contaminants. Using a dataset of 108 samples stimulated with five classes of PRR agonists, we could differentiate between these classes with more than 97% F1 on test data. We further demonstrate the model’s capacity to generalise on the previously unseen data using different ligands for the same PRRs as well as heat-killed Escherichia coli and Staphylococcus aureus .


  • Open Access

    Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids

    by Dimitra Athanasiou, Tess A. V. Afanasyeva, Niuzheng Chai, Kalliopi Ziaka, Katarina Jovanovic, Rosellina Guarascio, Karsten Boldt, Julio C. Corral-Serrano, Naheed Kanuga, Ronald Roepman, et al.

    Bialleleic pathogenic variants in LCA5 cause one of the most severe forms of Leber congenital amaurosis, an early-onset retinal disease that results in severe visual impairment. Here, we report the use of gene editing to generate isogenic LCA5 knock-out (LCA5 KO) induced pluripotent stem cells (iPSC) and their differentiation to retinal organoids. The molecular and cellular phenotype of the LCA5 KO retinal organoids was studied in detail and compared to isogenic controls as well as patient-derived retinal organoids. The absence of LCA5 was confirmed in retinal organoids by immunohistochemistry and western blotting. There were no major changes in retinal organoid differentiation or ciliation, however, the localisation of CEP290 and IFT88 was significantly altered in LCA5 KO and patient photoreceptor cilia with extension along the axoneme. The LCA5-deficient organoids also had shorter outer segments and rhodopsin was mislocalised to the outer nuclear layer. We also identified transcriptomic and proteomic changes associated with the loss of LCA5. Importantly, treatment with the small molecules eupatilin, fasudil or a combination of both drugs reduced CEP290 and IFT88 accumulation along the cilia. The treatments also improved rhodopsin traffic to the outer segment and reduced mislocalisation of rhodopsin in the outer nuclear layer (ONL). The improvements in cilia-associated protein localisation and traffic were accompanied by significant changes in the transcriptome towards control gene expression levels in many of the differentially expressed genes. In summary, iPSC-derived retinal organoids are a powerful model for investigating the molecular and cellular changes associated with loss of LCA5 function and highlight the therapeutic potential of small molecules to treat retinal ciliopathies.


  • Open Access

    CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids

    by Tess A.V. Afanasyeva, Dimitra Athanasiou, Pedro R.L. Perdigao, Kae R. Whiting, Lonneke Duijkers, Galuh D.N. Astuti, Jean Bennett, Alejandro Garanto, Jacqueline van der Spuy, Ronald Roepman, et al.